Day: February 22, 2021

Santa Monica, CA, Feb. 22, 2021 (GLOBE NEWSWIRE) — Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics and wearable beauty and health technology innovator, is making a strong push into the growing pregnancy beauty market on the heels of a mention by international supermodel and beauty influencer Gigi Hadid, who stated that she used Oliveda products produced by Oliveda International’s second-tier subsidiary during her recent pregnancy.  The video can be seen at can been seen at https://www.vogue.com/article/gigi-hadid-beauty-secrets.According to industry research firms, the global pregnancy care products market size was valued at over $23 million in 2019 and is expected to reach almost $42 million by 2026, growing at a CAGR of approximately 6% during the 2020 to 2026 forecast period.  In recent years...

CPI FIM SA (société anonyme)                                                                                                                                                     40, rue de la ValléeL-2661 Luxembourg                                                                                                                                                        R.C.S. Luxembourg: B 44.996Corporate News                                                                                                                                                                                                          Luxembourg, 22 February 2021                                                                                                             CPI FIM SA  – Participation in the share buy-back of CPI PROPERTY GROUPCPI FIM SA (the “Company“)...

FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%Libtayo was superior in extending overall survival compared to chemotherapy in a pivotal trial that allowed for certain disease characteristics frequently underrepresented in advanced NSCLC trialsThis is the third approval for Libtayo in the U.S.PARIS and TARRYTOWN, N.Y. – February 22, 2021 – The U.S. Food and Drug Administration (FDA) has approved the PD-1 inhibitor Libtayo® (cemiplimab-rwlc) for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression (tumor proportion score ≥50%), as determined by an FDA-approved test. Patients must either have metastatic or locally advanced tumors that are not candidates for surgical...

                                                                                                                                                            La FDA approuve Libtayo® (cemiplimab-rwlc) en monothérapie pour le traitement de première ligne du cancer du poumon non à petites cellules dont 50 % ou plus des cellules tumorales expriment la protéine PD-L1L’effet de Libtayo sur la prolongation de la survie globale a été supérieur à celui de la chimiothérapie dans le cadre d’un essai pivot ayant pris en compte des caractéristiques de la maladie souvent sous représentées dans les essais cliniques consacrés au CPNPC au stade avancéTroisième indication approuvée pour Libtayo aux États-Unis.PARIS et TARRYTOWN (New York) – Le 22 février 2021 – La Food and Drug Administration (FDA) des États-Unis a approuvé l’inhibiteur de PD-1 Libtayo®...

BROOKFIELD, NEWS, Feb. 22, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN), together with its institutional partners (collectively, “Brookfield Infrastructure”) commenced its formal offer (the “Offer”) to acquire all of the outstanding common shares of Inter Pipeline Ltd. (“IPL” or the “Company”).The notice and advertisement of the Offer appear in the Monday, February 22, 2021 editions of The Globe and Mail and Le Devoir, and the Offer is contained in the Offer to Purchase and Bid Circular (the “Offer and Circular”) and related documents, which have been filed with the Canadian securities regulators on SEDAR under IPL’s profile at www.sedar.com. The Offer and Circular will be mailed to all IPL shareholders upon receipt of the list of holders of Common Shares previously requested by Brookfield...

Acquisition of the office building of the “Esprit Courbevoie” project in Louvain-la-NeuveBefimmo has acquired a 94-year long lease on the office building of the “Esprit Courbevoie” project, in state of future completion, for an amount of approximately € 27 million. The expected yield on investment is 5.6%.Click here for the full press release:AttachmentBefimmo SA – Courbevoie – 2021.02.22 – UK – FINAL_2

Acquisition de l’immeuble de bureaux du projet Esprit Courbevoie à Louvain-la-NeuveBefimmo a acquis un droit d’emphytéose de 94 ans sur l’immeuble de bureaux du projet Esprit Courbevoie, en état de futur achèvement, pour un montant de l’ordre de 27 millions €. Le rendement attendu sur investissement s’élève à 5,6%.Cliquez ici pour consulter le communiqué de presse complet :Pièce jointeBefimmo SA – Courbevoie – 2021.02.22 – FR – FINAL_2

Aankoop van het kantoorgebouw van het “Esprit Courbevoie” project in Louvain-la-NeuveBefimmo heeft voor een bedrag van ongeveer € 27 miljoen een erfpacht van 94 jaar aangekocht op het kantoorgebouw van het project “Esprit Courbevoie”, in staat van toekomstige afwerking. Het verwachte rendement op de investering bedraagt 5,6%.Klik hier om het volledige persbericht te raadplegen:BijlageBefimmo SA – Courbevoie – 2021.02.22 – NL – FINAL_2

SALT LAKE CITY, Feb. 22, 2021 (GLOBE NEWSWIRE) — ZAGG Inc (Nasdaq: ZAGG) (“we,” “us,” “our,” “ZAGG,” or the “Company”), a leading global mobile lifestyle company, today announced the completion of its sale to a buyer group led by Evercel, Inc. (“Evercel”).The transaction was previously announced on December 11, 2020 and received approval from ZAGG’s stockholders on February 18, 2021. As a result of the completion of the transaction, ZAGG’s stockholders will receive $4.20 per share in cash and a contingent right to receive an additional payment of up to $0.30 per share, and ZAGG’s common stock will cease to trade on the Nasdaq Global Select exchange.About ZAGG IncZAGG Inc (NASDAQ: ZAGG) is a global leader in accessories and technologies that empower mobile lifestyles. The Company has an award-winning product portfolio that includes...

Raison sociale de l’émetteur : Société Générale S.A. – SA au capital de 1 066 714 367,50 euros                                                                     Immatriculée sous le n° 552 120 222 R.C.S. PARIS                                                                     Siège social : 29, Boulevard Haussmann, 75009 ParisPièce jointeSociété Générale actions et droits de vote au 31-01-2021